| 내 용 |
I"m a partner in http://kratom.in.net/ kratom online Some analysts have expressed surprise at the extent of the clinical programme undertaken for a biosimilar. It has been claimed in some circles that an extensive data package has been submitted in a bid to boost Lilly and Boehringer"s commercial prospects against Lantus, assuming their "similar" drug gets approved.
|
